About Med-X
Med-X is a private company based in Canoga Park, California. It has reported $4,969,799 raised in 17 offerings on Form D since October 2014. Its chief executive is Matthew Mills.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Sep 26, 2025 | $0of $10.3M target | 0 | — | EquityRule 506(c) | Form D ↗ |
| Jun 3, 2025 | Jun 4, 2025 | $250,000of $3.4M target | 1 | $250K | EquityRule 506(c) | Form D ↗ |
| Jan 23, 2025 | Feb 11, 2025amended Feb 12, 2025 | $427,500of $2.3M target | 6 | $71,250 | EquityRule 506(c) | Form D/A ↗1 earlier filing |
| Sep 17, 2024 | Sep 26, 2024amended Sep 30, 2024 | $837,500of $2.3M target | 2 | $418K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| May 14, 2024 | May 21, 2024 | $250,000of $2.3M target | 2 | $125K | EquityRule 506(b) | Form D ↗ |
| Feb 27, 2024 | Mar 7, 2024 | $100,000of $1.1M target | 5 | $20,000 | EquityRule 506(c) | Form D ↗ |
| May 6, 2023 | May 17, 2023 | $120,000of $3.4M target | 5 | $24,000 | EquityRule 506(c) | Form D ↗ |
| Oct 28, 2022 | Nov 8, 2022 | $100,000of $3.4M target | 1 | $100K | EquityRule 506(c) | Form D ↗ |
| Oct 1, 2021 | Oct 29, 2021 | $1,198,999of $3.4M target | 4 | $299K | EquityRule 506(c) | Form D ↗ |
| Apr 2, 2021 | Apr 23, 2021 | $225,000of $3.4M target | 2 | $112K | EquityRule 506(c) | Form D ↗ |
| Mar 26, 2020 | Jun 23, 2020 | $600,000of $3.0M target | 3 | $200K | EquityRule 506(c) | Form D ↗ |
| Mar 12, 2019 | Aug 9, 2019amended Aug 12, 2019 | $467,300of $3.0M target | 15 | $31,153 | EquityRule 506(c) | Form D/A ↗1 earlier filing |
| Feb 2, 2018 | Feb 16, 2018 | $229,000of $3.4M target | 9 | $25,444 | EquityRule 506(c) | Form D ↗ |
| Mar 14, 2017 | May 3, 2017 | $12,000of $3.4M target | 1 | $12,000 | EquityRule 506(c) | Form D ↗ |
| Oct 14, 2016 | Oct 31, 2016 | $47,000of $1.3M target | 7 | $6,714 | EquityRule 506(c) | Form D ↗ |
| Sep 16, 2015 | Oct 21, 2015 | $55,500of $2.8M target | 5 | $11,100 | EquityRule 506(c) | Form D ↗ |
| Sep 15, 2014 | Oct 1, 2014 | $50,000of $5.5M target | 1 | $50,000 | EquityRule 506(c) | Form D ↗ |
| Total, 17 offerings | $4,969,799 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Med-X's Form D filed Sep 26, 2025.
FJ
Fred Dashiell, Jr.
Director
JM
Jennifer Mills
Executive officer and director
MM
Matthew Mills
Chief Executive Officer and director
MK
Michael Kuntz
Director
RT
Ronald Tchorzewski
Executive officer and director
AK
Allan Kurtz
Director
MW
Mary Kay Wilson
Director
Earlier filings also listed Morton Hyson (director, last listed Jun 2025), Nicholas Phillips (executive officer, last listed Sep 2024), David Toomey (executive officer, last listed Sep 2024) and Mark Richardson (director, last listed Oct 2014).